The research from the Boyce Thompson Institute focuses on neurotransmitter serotonin, which carries messages between nerve cells and is thought to play a role in several mental health conditions.
Three Cornell faculty members and a senior lecturer have been recognized with Kendall S. Carpenter Memorial Advising Awards for their sustained and distinguished contributions.
Weill Cornell Medicine’s debt-reduction program was created in 2019 to cover tuition, fees, housing and living expenses for students with financial need.
The activity of a gene called CIART is a key factor in the establishment of the viral infection that causes COVID-19, according to a study from researchers at Weill Cornell Medicine and New York University Grossman School of Medicine.
MicroRNA (miRNA) molecules in pancreatic islets have been thought to play important roles in Type 2 diabetes, but until now scientists have not confidently identified which miRNAs are associated with the disease in humans.
New research from the Tata-Cornell Institute for Agriculture and Nutrition (TCI) sheds light on the patterns of obesity within India, underscoring the need for policies and programs that consider the factors driving obesity rates within different groups and communities.
Stores nationwide have been struggling to stock enough baby formula to meet demand for parents. Cornell experts weigh in on suggested alternatives and dangerous substitutions as the baby formula shortage drags on.
Enforcement of New York City’s vaccine mandate for uniformed service providers begins today. Lee Adler says the city’s uniformed service providers are potentially risking reputational damage and the high number of unvaccinated firefighters will likely result in service limitations.
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
Compared with men, women continue to have a roughly 30-40% higher risk of dying following coronary artery bypass surgery, according to a large study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
